Time
-

NEWS

NEWS

Five mRNA core enzymes completed DMF filing

A variety of mRNA raw material enzymes of Yeasen Bio obtained FDA DMF filing

2022-11-18 17:11:41

An invitation letter —— Meet Yeasen at ASCB & EMBO 2022 in Washington, DC

Yeasen will attend ASCB 2022, and our team is excited to see you at the meeting in person.

2022-11-18 16:11:19

Overseas Expo|Meet Yeasen at Medlab Asia & Asia Health 2022, providing IVD solutions for biotech customers

2022-10-26 16:37:59

The principles of DNase I footprinting and its biomedical applications

DNA footprinting technique was developed by David Galas and Albert Schmitz in Geneva in 1977. DNA footprinting is one of the early techniques used to study DNA-protein interactions and is a modification of the Maxam-Gilbert sequencing technique. A DNase I footprinting assay is a DNA footprinting technique in molecular biology/biochemistry. So what is the principle of DNase I footprinting? What biomedical applications are there?

2022-08-05 16:09:41

After the Exhibition|2022 AACC—Yeasen`s qPCR products help rapid molecular diagnostics

2022 AACC has come to a happy end and many biotech customers had a better understanding of Yeasen and Yeasen’s products and services.

2022-07-29 14:38:12